acute

(redirected from acute respiratory distress syndrome)
Also found in: Dictionary, Medical, Legal, Acronyms, Encyclopedia, Wikipedia.
Related to acute respiratory distress syndrome: Acute Respiratory Failure
Graphic Thesaurus  🔍
Display ON
Animation ON
Legend
Synonym
Antonym
Related
  • all
  • adj
  • noun

Synonyms for acute

Synonyms for acute

possessing or displaying perceptions of great accuracy and sensitivity

so serious as to be at the point of crisis or necessary to resolve a crisis

marked by severity or intensity

Synonyms for acute

a mark (') placed above a vowel to indicate pronunciation

having or experiencing a rapid onset and short but severe course

extremely sharp or intense

Synonyms

Related Words

having or demonstrating ability to recognize or draw fine distinctions

of an angle

Antonyms

ending in a sharp point

Related Words

of critical importance and consequence

Related Words

References in periodicals archive ?
Neuromuscular blockers in early acute respiratory distress syndrome.
Extracorporeal Membrane Oxygenation for 2009 Influenza A(H1N1) Acute Respiratory Distress Syndrome.
Analysis of key recent licensing and partnership agreements in Acute Respiratory Distress Syndrome Therapeutics market
Coverage of the Acute Respiratory Distress Syndrome pipeline on the basis of route of administration and molecule type.
Acute respiratory distress syndrome in pregnancy and the puerperium: causes, courses and outcomes.
HMPV could have led to the acute respiratory distress syndrome in this immunocompromised patient.
GlobalData, the industry analysis specialist, has released its new report, Acute Respiratory Distress Syndrome (ARDS) Therapeutics - Pipeline Assessment and Market Forecasts to 2017.
The Company has filed applications to market ABLC(R) in Europe and is conducting Phase II/III of ABLC(R) studies for the treatment of systemic fungal infections in the US; TLC D-99 will be starting Phase III trials for the treatment of metastatic breast cancer; TLC C-53 is currently in Phase I/II trials for the treatment of Acute Respiratory Distress Syndrome (ARDS) in the US and Phase I trials for Systemic Inflammatory Response Syndrome (SIRS) in Europe; TLC A-60 has entered Phase I trials as a liposomal adjuvant to be used in an influenza virus vaccine.
Each of the product candidates is designed with advantages over currently marketed products in major markets including acute respiratory distress syndrome, stroke, myocardial infarction, surgery, trauma, malignant tumors and diabetes.
System Dysfunction Associated With ARDS BOSTON, May 23 /PRNewswire/ -- Clinical researchers have reported promising results from a Phase II study designed to measure the effect of Procysteine(R) on organ dysfunction in patients with Acute Respiratory Distress Syndrome (ARDS).
Phase II/III studies for the treatment of systemic fungal infections; TLC D-99 has completed Phase II trials for the treatment of metastatic breast cancer; TLC C-53 is currently in Phase I/II trials in Acute Respiratory Distress Syndrome (ARDS); and Maitec(R) has completed Phase II trials in the U.
and Phase III trials in Europe for the treatment of Mycobacterium avium-intracellulare (MAI), an infection that eventually strikes 30 to 50 percent of people with AIDS; TLC D-99 has completed Phase II trials for treatment for metastatic breast cancer; and TLC C-53 has completed Phase I trials in preparation for a Phase II study in Acute Respiratory Distress Syndrome.
and Phase III trials in Europe for the treatment of Mycobacterium avium-intracellulare (MAI), an infection that eventually strikes 30 to 50 percent of people with AIDS; TLC D-99 has completed Phase II for treatment of metastatic breast cancer; and TLC C-53 has completed Phase I trials in preparation for a Phase II study in Acute Respiratory Distress Syndrome.
and Phase III trials in Europe for the treatment of Mycobacterium avium-intracellulare (MAI), an infection that eventually strike 30 to 50 percent of people with AIDS; TLC D-99 has completed Phase II for treatment of metastatic breast cancer; and TLC C-53 has completed Phase I trials in preparation for a Phase II study in Acute Respiratory Distress Syndrome.
The Intravenous Membrane Oxygenator (IMO) is intended to provide temporary support for patients with acute respiratory distress syndrome (ARDS).
Full browser ?